295 related articles for article (PubMed ID: 21871428)
1. Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas.
Cheunsuchon P; Zhou Y; Zhang X; Lee H; Chen W; Nakayama Y; Rice KA; Tessa Hedley-Whyte E; Swearingen B; Klibanski A
Am J Pathol; 2011 Oct; 179(4):2120-30. PubMed ID: 21871428
[TBL] [Abstract][Full Text] [Related]
2. Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas.
Gejman R; Batista DL; Zhong Y; Zhou Y; Zhang X; Swearingen B; Stratakis CA; Hedley-Whyte ET; Klibanski A
J Clin Endocrinol Metab; 2008 Oct; 93(10):4119-25. PubMed ID: 18628527
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of DLK1/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors.
Chen Y; Gao H; Liu Q; Xie W; Li B; Cheng S; Guo J; Fang Q; Zhu H; Wang Z; Wang J; Li C; Zhang Y
Aging (Albany NY); 2020 Dec; 13(1):1422-1439. PubMed ID: 33472171
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the Paternally-Imprinted DLK1-MEG3 and IGF2-H19 Tandem Gene Loci in NT2 Embryonal Carcinoma Cells Identifies DLK1 as a Potential Therapeutic Target.
Sellers ZP; Schneider G; Maj M; Ratajczak MZ
Stem Cell Rev Rep; 2018 Dec; 14(6):823-836. PubMed ID: 29980981
[TBL] [Abstract][Full Text] [Related]
5. CXCL12-regulated miR-370-3p functions as a tumor suppressor gene by targeting HMGA2 in nonfunctional pituitary adenomas.
Cai F; Dai C; Chen S; Wu Q; Liu X; Hong Y; Wang Z; Li L; Yan W; Wang R; Zhang J
Mol Cell Endocrinol; 2019 May; 488():25-35. PubMed ID: 30853598
[TBL] [Abstract][Full Text] [Related]
6. Loss of non-coding RNA expression from the DLK1-DIO3 imprinted locus correlates with reduced neural differentiation potential in human embryonic stem cell lines.
Mo CF; Wu FC; Tai KY; Chang WC; Chang KW; Kuo HC; Ho HN; Chen HF; Lin SP
Stem Cell Res Ther; 2015 Jan; 6(1):1. PubMed ID: 25559585
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line.
Chunharojrith P; Nakayama Y; Jiang X; Kery RE; Ma J; De La Hoz Ulloa CS; Zhang X; Zhou Y; Klibanski A
Mol Cell Endocrinol; 2015 Nov; 416():27-35. PubMed ID: 26284494
[TBL] [Abstract][Full Text] [Related]
8. At least ten genes define the imprinted Dlk1-Dio3 cluster on mouse chromosome 12qF1.
Hagan JP; O'Neill BL; Stewart CL; Kozlov SV; Croce CM
PLoS One; 2009; 4(2):e4352. PubMed ID: 19194500
[TBL] [Abstract][Full Text] [Related]
9. Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival.
Sellers ZP; Bolkun L; Kloczko J; Wojtaszewska ML; Lewandowski K; Moniuszko M; Ratajczak MZ; Schneider G
Clin Epigenetics; 2019 Mar; 11(1):50. PubMed ID: 30876483
[TBL] [Abstract][Full Text] [Related]
10.
Yen YP; Hsieh WF; Tsai YY; Lu YL; Liau ES; Hsu HC; Chen YC; Liu TC; Chang M; Li J; Lin SP; Hung JH; Chen JA
Elife; 2018 Oct; 7():. PubMed ID: 30311912
[TBL] [Abstract][Full Text] [Related]
11. Expression analysis of GADD45γ, MEG3, and p8 in pituitary adenomas.
Binse I; Ueberberg B; Sandalcioglu IE; Flitsch J; Luedecke DK; Mann K; Petersenn S
Horm Metab Res; 2014 Aug; 46(9):644-50. PubMed ID: 25126861
[TBL] [Abstract][Full Text] [Related]
12. Loss of imprinting and allelic switching at the DLK1-MEG3 locus in human hepatocellular carcinoma.
Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Lehmann U
PLoS One; 2012; 7(11):e49462. PubMed ID: 23145177
[TBL] [Abstract][Full Text] [Related]
13. Expressed alleles of imprinted IGF2, DLK1 and MEG3 colocalize in 3D-preserved nuclei of porcine fetal cells.
Lahbib-Mansais Y; Barasc H; Marti-Marimon M; Mompart F; Iannuccelli E; Robelin D; Riquet J; Yerle-Bouissou M
BMC Cell Biol; 2016 Oct; 17(1):35. PubMed ID: 27716032
[TBL] [Abstract][Full Text] [Related]
14. Mouse Peg9/Dlk1 and human PEG9/DLK1 are paternally expressed imprinted genes closely located to the maternally expressed imprinted genes: mouse Meg3/Gtl2 and human MEG3.
Kobayashi S; Wagatsuma H; Ono R; Ichikawa H; Yamazaki M; Tashiro H; Aisaka K; Miyoshi N; Kohda T; Ogura A; Ohki M; Kaneko-Ishino T; Ishino F
Genes Cells; 2000 Dec; 5(12):1029-37. PubMed ID: 11168589
[TBL] [Abstract][Full Text] [Related]
15. Expression of cell growth negative regulators MEG3 and GADD45γ is lost in most sporadic human pituitary adenomas.
Mezzomo LC; Gonzales PH; Pesce FG; Kretzmann Filho N; Ferreira NP; Oliveira MC; Kohek MB
Pituitary; 2012 Sep; 15(3):420-7. PubMed ID: 21850407
[TBL] [Abstract][Full Text] [Related]
16. The paternally imprinted DLK1-GTL2 locus is differentially methylated in embryonal and alveolar rhabdomyosarcomas.
Schneider G; Bowser MJ; Shin DM; Barr FG; Ratajczak MZ
Int J Oncol; 2014 Jan; 44(1):295-300. PubMed ID: 24173021
[TBL] [Abstract][Full Text] [Related]
17. Deregulation of the imprinted DLK1-DIO3 locus ncRNAs is associated with replicative senescence of human adipose-derived stem cells.
García-López S; Albo-Castellanos C; Urdinguio RG; Cañón S; Sánchez-Cabo F; Martínez-Serrano A; Fraga MF; Bernad A
PLoS One; 2018; 13(11):e0206534. PubMed ID: 30395586
[TBL] [Abstract][Full Text] [Related]
18. Abnormal DLK1/MEG3 imprinting correlates with decreased HERV-K methylation after assisted reproduction and preimplantation genetic diagnosis.
Dimitriadou E; Noutsopoulos D; Markopoulos G; Vlaikou AM; Mantziou S; Traeger-Synodinos J; Kanavakis E; Chrousos GP; Tzavaras T; Syrrou M
Stress; 2013 Nov; 16(6):689-97. PubMed ID: 23786541
[TBL] [Abstract][Full Text] [Related]
19. Expression of neuro D1 in human normal pituitaries and pituitary adenomas.
Oyama K; Sanno N; Teramoto A; Osamura RY
Mod Pathol; 2001 Sep; 14(9):892-9. PubMed ID: 11557786
[TBL] [Abstract][Full Text] [Related]
20. The Dysregulation of the
Kameswaran V; Golson ML; Ramos-Rodríguez M; Ou K; Wang YJ; Zhang J; Pasquali L; Kaestner KH
Diabetes; 2018 Sep; 67(9):1807-1815. PubMed ID: 30084829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
